BIOMAT Database Logo BIOMAT Database Logo

Severe thrombophlebitis with naftidrofuryl oxalate. 1977

M Gann

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D009257 Nafronyl A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors. Nafronyloxalate,Naftidrofuryl,Artocoron,Azunaftil,Di-Actane,Dusodril,Gévatran,LS-121,Nafronyl Oxalate,Nafti Von Ct,Nafti-Puren,Nafti-Ratiopharm,Naftifurin Oxalate,Naftilong,Naftilux,Praxilene,Praxilène,Di Actane,LS 121,LS121,Nafti Puren,Nafti Ratiopharm,NaftiRatiopharm,Oxalate, Nafronyl,Oxalate, Naftifurin
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

M Gann
Thrombophlebitis with intravenous naftidrofuryl oxalate.
October 1977, British medical journal,
M Gann
Incidence of thrombophlebitis with naftidrofuryl.
March 1978, British medical journal,
M Gann
Recurrent calcium oxalate nephrolithiasis induced by naftidrofuryl oxalate.
May 2000, Nephron,
M Gann
Calcium oxalate crystalluria in elderly patients and treatment with naftidrofuryl oxalate.
November 1995, Age and ageing,
M Gann
Renal intratubular crystallisation of calcium oxalate and naftidrofuryl oxalate.
November 1991, Lancet (London, England),
M Gann
[Effects of naftidrofuryl oxalate on peripheral circulation].
September 1973, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Gann
[Therapy of algodystrophy (Sudeck disease) with naftidrofuryl hydrogen oxalate (NH)].
March 1986, Der Unfallchirurg,
M Gann
Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate.
January 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Gann
[Protective effects of naftidrofuryl oxalate against hypoxia-induced death].
April 1992, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Gann
Gastric mucosal cytoprotection in the rat by naftidrofuryl oxalate.
February 1990, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!